Synaptotagmin IV Inhibitors

Synaptotagmin IV inhibitors encompass a broad spectrum of chemical entities that indirectly influence the protein's function by modulating the cellular and molecular pathways associated with its activity. These inhibitors do not bind directly to Synaptotagmin IV but exert their effects by altering the intracellular calcium concentration, which is crucial for Synaptotagmin IV's role in neurotransmitter release and synaptic plasticity.

The chemical class includes calcium chelators like BAPTA-AM and EGTA, which sequester calcium ions and prevent them from activating Synaptotagmin IV. Anticonvulsants like gabapentin and lamotrigine indirectly alter neuronal excitability and synaptic vesicle release, processes in which Synaptotagmin IV is implicated. Phorbol esters, such as PMA, activate protein kinase C, which can phosphorylate and thereby modulate the function of Synaptotagmin IV. Specific ion channel blockers like tetrodotoxin, ω-conotoxins, and ω-agatoxin IVA target sodium and calcium channels, respectively, influencing synaptic activity and potentially the role of Synaptotagmin IV in these processes.